Suppr超能文献

转化生长因子-β(TGF-β)诱导纤溶酶原激活物抑制剂-1(PAI-1)启动子中p53/ Smads复合物形成以激活转录。

TGF-β induces p53/Smads complex formation in the PAI-1 promoter to activate transcription.

作者信息

Kawarada Yuki, Inoue Yasumichi, Kawasaki Fumihiro, Fukuura Keishi, Sato Koichi, Tanaka Takahito, Itoh Yuka, Hayashi Hidetoshi

机构信息

Department of Cell Signaling, Graduate School of Pharmaceutical Sciences, Nagoya City University, 467-8603 Nagoya, Japan.

Department of Innovative Therapeutics Sciences, Cooperative major in Nanopharmaceutical Sciences, Graduate School of Pharmaceutical Sciences, Nagoya City University, 467-8603 Nagoya, Japan.

出版信息

Sci Rep. 2016 Oct 19;6:35483. doi: 10.1038/srep35483.

Abstract

Transforming growth factor β (TGF-β) signaling facilitates tumor development during the advanced stages of tumorigenesis, but induces cell-cycle arrest for tumor suppression during the early stages. However, the mechanism of functional switching of TGF-β is still unknown, and it is unclear whether inhibition of TGF-β signaling results amelioration or exacerbation of cancers. Here we show that the tumor suppressor p53 cooperates with Smad proteins, which are TGF-β signal transducers, to selectively activate plasminogen activator inhibitor type-1 (PAI-1) transcription. p53 forms a complex with Smad2/3 in the PAI-1 promoter to recruit histone acetyltransferase CREB-binding protein (CBP) and enhance histone H3 acetylation, resulting in transcriptional activation of the PAI-1 gene. Importantly, p53 is required for TGF-β-induced cytostasis and PAI-1 is involved in the cytostatic activity of TGF-β in several cell lines. Our results suggest that p53 enhances TGF-β-induced cytostatic effects by activating PAI-1 transcription, and the functional switching of TGF-β is partially caused by p53 mutation or p53 inactivation during cancer progression. It is expected that these findings will contribute to optimization of TGF-β-targeting therapies for cancer.

摘要

转化生长因子β(TGF-β)信号传导在肿瘤发生的晚期促进肿瘤发展,但在早期诱导细胞周期停滞以抑制肿瘤。然而,TGF-β功能转换的机制仍然未知,并且尚不清楚抑制TGF-β信号传导是否会导致癌症改善或恶化。在这里,我们表明肿瘤抑制因子p53与作为TGF-β信号转导分子的Smad蛋白协同作用,以选择性激活1型纤溶酶原激活物抑制剂(PAI-1)转录。p53在PAI-1启动子中与Smad2/3形成复合物,以募集组蛋白乙酰转移酶CREB结合蛋白(CBP)并增强组蛋白H3乙酰化,从而导致PAI-1基因的转录激活。重要的是,p53是TGF-β诱导的细胞停滞所必需的,并且PAI-1在几种细胞系中参与TGF-β的细胞停滞活性。我们的结果表明,p53通过激活PAI-1转录增强TGF-β诱导的细胞停滞作用,并且TGF-β的功能转换部分是由癌症进展过程中的p53突变或p53失活引起的。预计这些发现将有助于优化针对癌症的TGF-β靶向治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bad/5069723/4fd2b3802da4/srep35483-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验